NO920331L - Biologisk preparat samt bruk derav - Google Patents

Biologisk preparat samt bruk derav

Info

Publication number
NO920331L
NO920331L NO92920331A NO920331A NO920331L NO 920331 L NO920331 L NO 920331L NO 92920331 A NO92920331 A NO 92920331A NO 920331 A NO920331 A NO 920331A NO 920331 L NO920331 L NO 920331L
Authority
NO
Norway
Prior art keywords
biological preparation
antigenic
relates
material derived
treatment against
Prior art date
Application number
NO92920331A
Other languages
English (en)
Other versions
NO920331D0 (no
Inventor
John Lawson Standford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of NO920331D0 publication Critical patent/NO920331D0/no
Publication of NO920331L publication Critical patent/NO920331L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Anvendelse av antigent og/eller immunoregulatorisk materiele avledet fravcobacterium vaccae for immuno-profylaktisk behandling mot AIDS syndrom.
NO92920331A 1989-07-28 1992-01-24 Biologisk preparat samt bruk derav NO920331L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898917256A GB8917256D0 (en) 1989-07-28 1989-07-28 Biological preparation and its use
PCT/GB1990/001169 WO1991001751A1 (en) 1989-07-28 1990-07-27 Biological preparation and its use

Publications (2)

Publication Number Publication Date
NO920331D0 NO920331D0 (no) 1992-01-24
NO920331L true NO920331L (no) 1992-01-24

Family

ID=10660759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920331A NO920331L (no) 1989-07-28 1992-01-24 Biologisk preparat samt bruk derav

Country Status (13)

Country Link
EP (1) EP0484438B1 (no)
JP (1) JPH05500803A (no)
AT (1) ATE136467T1 (no)
AU (1) AU644376B2 (no)
CA (1) CA2064029C (no)
DE (1) DE69026506T2 (no)
DK (1) DK0484438T3 (no)
ES (1) ES2088431T3 (no)
FI (1) FI920356A0 (no)
GB (1) GB8917256D0 (no)
NO (1) NO920331L (no)
WO (1) WO1991001751A1 (no)
ZA (1) ZA905927B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
US6284255B1 (en) 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2472481A1 (en) * 2001-01-17 2002-07-25 Bakulesh Mafatlal Khamar Use of mycobacterium w for the treatment of human immunodeficiency virus (hiv) disease infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Also Published As

Publication number Publication date
GB8917256D0 (en) 1989-09-13
NO920331D0 (no) 1992-01-24
ZA905927B (en) 1991-05-29
WO1991001751A1 (en) 1991-02-21
FI920356A0 (fi) 1992-01-27
AU644376B2 (en) 1993-12-09
DE69026506D1 (de) 1996-05-15
DE69026506T2 (de) 1996-09-12
EP0484438A1 (en) 1992-05-13
ATE136467T1 (de) 1996-04-15
ES2088431T3 (es) 1996-08-16
JPH05500803A (ja) 1993-02-18
DK0484438T3 (da) 1996-06-10
AU6188390A (en) 1991-03-11
EP0484438B1 (en) 1996-04-10
CA2064029C (en) 1998-12-29
CA2064029A1 (en) 1991-01-29

Similar Documents

Publication Publication Date Title
DK0556241T3 (da) Mycobacterium vaccae til behandling af uveitis
NO920331L (no) Biologisk preparat samt bruk derav
NL300401I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
DE69309915D1 (de) Mycobacterium Vaccae zur Behandlung von langwierigen Autoimmunerkrankungen
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
BR9303762A (pt) Uso de material antigenico e/ou imunorregulatorio derivado de mycobacterium vaccae,processo para o tratamento de infeccao por hiv com ou sem aids,produtos e agente imunoterapeutico
MX9100808A (es) Antigenos superficiales inmunodominantes de la entomoeba histolitica.
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.